JAZZ · Categories · Downgrades
JAZZ - Analyst downgrades
Jazz Pharmaceuticals plc (JAZZ) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for JAZZ
- Jazz Pharma downgraded by UBS with a new price targetUBS downgraded Jazz Pharma from Buy to Neutral and set a new price target of $188.00
- Jazz Pharma downgraded by Cantor FitzgeraldCantor Fitzgerald downgraded Jazz Pharma from Overweight to Neutral
- Jazz Pharma downgraded by UBS with a new price targetUBS downgraded Jazz Pharma from Buy to Neutral and set a new price target of $135.00 from $170.00 previously
- Jazz Pharma downgraded by Goldman with a new price targetGoldman downgraded Jazz Pharma from Buy to Neutral and set a new price target of $196.00 from $202.00 previously
- Jazz Pharmaceuticals downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Jazz Pharmaceuticals from Overweight to Equal-Weight and set a new price target of $162.00 from $177.00 previously
- Jazz Pharma downgraded by Morgan StanleyMorgan Stanley downgraded Jazz Pharma from Overweight to Equal-Weight